SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-006246
Filing Date
2017-04-10
Accepted
2017-04-10 08:10:22
Documents
5
Period of Report
2017-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omed-8k_20170410.htm 8-K 37356
2 EX-99.1 omed-ex991_9.htm EX-99.1 28598
3 EX-99.2 omed-ex992_8.htm EX-99.2 11374
4 GRAPHIC g20170410053141263122.jpg GRAPHIC 12741
5 GRAPHIC g20170410053150207108.jpg GRAPHIC 12741
  Complete submission text file 0001564590-17-006246.txt   113819
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 17751701
SIC: 2834 Pharmaceutical Preparations